Ann S. Knoop
Oncological Research Center
Odense University Hospital
Odense
Denmark
Name/email consistency: high
- retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. Knoop, A.S., Knudsen, H., Balslev, E., Rasmussen, B.B., Overgaard, J., Nielsen, K.V., Schonau, A., Gunnarsdóttir, K., Olsen, K.E., Mouridsen, H., Ejlertsen, B. J. Clin. Oncol. (2005)
- Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients. Knoop, A.S., Bentzen, S.M., Nielsen, M.M., Rasmussen, B.B., Rose, C. J. Clin. Oncol. (2001)